Literature DB >> 12078822

Determining the extent of cognitive change after coronary surgery: a review of statistical procedures.

Alexander Collie1, David G Darby, Marina G Falleti, Brendan S Silbert, Paul Maruff.   

Abstract

Currently, cognitive decline after coronary surgery is said to be significant if the individual's postoperative test score is at least 1 standard deviation (SD) worse than their preoperative score. This "1-SD" technique fails to account for factors that may confound interpretation of serially acquired cognitive test scores, including regression to the mean, measurement error caused by poor test-retest reliability, and practice effects. We review the many alternative and potentially superior statistical techniques that have been described in the neuropsychologic and psychiatric literature for differentiating "true" changes in cognitive test score from changes caused by these factors.

Entities:  

Mesh：

Year:  2002        PMID： 12078822     DOI： 10.1016/s0003-4975(01)03375-6

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN： 0003-4975            Impact factor:   4.330


  24 in total

1.  Are Reliable Change (RC) calculations appropriate for determining the extent of cognitive change in concussed athletes?

Authors:  A Collie; P Maruff; M McStephen; D Darby
Journal:  Br J Sports Med       Date:  2003-08       Impact factor: 13.800

2.  Postoperative cognitive dysfunction: computerized and conventional tests showed only moderate inter-rater reliability.

Authors:  Finn M Radtke; Martin Franck; Norbert Papkalla; Tim S Herbig; Edith Weiss-Gerlach; Robin Kleinwaechter; Klaus D Wernecke; Claudia D Spies
Journal:  J Anesth       Date:  2010-05-28       Impact factor: 2.078

Review 3.  Reliable change assessment in sport concussion research: a comment on the proposal and reviews of Collie et al.

Authors:  G H Maassen
Journal:  Br J Sports Med       Date:  2005-08       Impact factor: 13.800

4.  Dietary Factors and Cognitive Decline.

Authors:  P J Smith; J A Blumenthal
Journal:  J Prev Alzheimers Dis       Date:  2016-03

5.  Effect of more frequent hemodialysis on cognitive function in the frequent hemodialysis network trials.

Authors:  Manjula Kurella Tamura; Mark L Unruh; Allen R Nissenson; Brett Larive; Paul W Eggers; Jennifer Gassman; Ravindra L Mehta; Alan S Kliger; John B Stokes
Journal:  Am J Kidney Dis       Date:  2012-11-11       Impact factor: 8.860

6.  A statistical approach for classifying change in cognitive function in individuals following pharmacologic challenge: an example with alprazolam.

Authors:  Paul Maruff; John Werth; Bruno Giordani; Angela F Caveney; Douglas Feltner; Peter J Snyder
Journal:  Psychopharmacology (Berl)       Date:  2006-03-28       Impact factor: 4.530

7.  Effect of off-pump coronary artery bypass surgery on clinical, angiographic, neurocognitive, and quality of life outcomes: randomised controlled trial.

Authors:  Sharif Al-Ruzzeh; Shane George; Mahmoud Bustami; Jo Wray; Charles Ilsley; Thanos Athanasiou; Mohamed Amrani
Journal:  BMJ       Date:  2006-06-01

8.  Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance.

Authors:  Christina M Marra; Yu Zhao; David B Clifford; Scott Letendre; Scott Evans; Katherine Henry; Ronald J Ellis; Benigno Rodriguez; Robert W Coombs; Giovanni Schifitto; Justin C McArthur; Kevin Robertson
Journal:  AIDS       Date:  2009-07-17       Impact factor: 4.177

9.  Short-term practice effects in amnestic mild cognitive impairment: implications for diagnosis and treatment.

Authors:  Kevin Duff; Leigh J Beglinger; Sara Van Der Heiden; David J Moser; Stephan Arndt; Susan K Schultz; Jane S Paulsen
Journal:  Int Psychogeriatr       Date:  2008-04-11       Impact factor: 3.878

10.  The generalizability of neurocognitive test/retest data derived from a nonclinical sample for detecting change among two HIV+ cohorts.

Authors:  Andrew J Levine; Charles H Hinkin; Eric N Miller; James T Becker; Ola A Selnes; Bruce A Cohen
Journal:  J Clin Exp Neuropsychol       Date:  2007-08       Impact factor: 2.475
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.